Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II

Immunology

Volumn 128, Issue 3, 2009, Pages 381-392

  Rehm, Kristina E ^a   Connor, Ramsey F ^a   Jones, Gwendolyn J B ^a   Yimbu, Kenneth ^a   Mannie, Mark D ^a   Roper, Rachel L ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Antigen presentation; Apoptosis; Cytokine; Macrophage; Major histocompatibility complex; Poxvirus; Vaccinia

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST; IMMUNE RESPONSE; IMMUNE SYSTEM; MACROPHAGE; MODEL; MOUSE; NONHUMAN; PERITONEAL EXUDATE CELL; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS INFECTION; VIRUS INHIBITION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CELL LINE; CYTOKINES; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE EVASION; LYMPHOCYTE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; NITRIC OXIDE; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; VACCINIA; VACCINIA VIRUS; VIRULENCE;

EID: 70349659930     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03120.x     Document Type: Article

References (45)

1. Moss B. Poxviruses. In : Knipe DM, Howley PM, eds. Fields Virology, Vol. 2. Philadelphia : Lippincott Williams & Wilkins, 2001 : 2849 2884.
2. Mahalingam S, Damon IK, Lidbury BA. 25 years since the eradication of smallpox: why poxvirus research is still relevant. Trends Immunol 2004 25 : 636 639.
3. Damaso CR, Esposito JJ, Condit RC, Moussatche N. An emergent poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from Brazilian smallpox vaccine. Virol 2000 277 : 439 449.
4. Dhar AD, Werchniak AE, Li Y, Brennick JB, Goldsmith CS, Kline R, Damon I, Klaus SN. Tanapox infection in a college student. N Engl J Med 2004 350 : 361 366.
5. Stich A, Meyer H, Kohler B, Fleischer K. Tanapox: first report in a European traveller and identification by PCR. Trans R Soc Trop Med Hyg 2002 96 : 178 179.
6. Kolhapure RM, Deolankar RP, Tupe CD et al. Investigation of buffalopox outbreaks in Maharashtra State during 1992-1996. Indian J Med Res 1997 106 : 441 446.
7. Konya J, Thompson CH. Molluscum contagiosum virus: antibody responses in persons with clinical lesions and seroepidemiology in a representative Australian population. J Infect Dis 1999 179 : 701 704.
8. Molino AC, Fleischer AB Jr., Feldman SR. Patient demographics and utilization of health care services for molluscum contagiosum. Pediatr Dermatol 2004 21 : 628 632.
9. Chen N, Li G, Liszewski MK et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virol 2005 340 : 46 63.
10. Casey CG, Iskander JK, Roper MH et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 2005 294 : 2734 2743.
11. Arness MK, Eckart RE, Love SS et al. Myopericarditis following smallpox vaccination. Am J Epidemiol 2004 160 : 642 651.
12. Eckart RE, Love SS, Atwood JE et al. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol 2004 44 : 201 205.
13. Upfal MJ, Cinti S. Smallpox vaccination and adverse cardiac events. Emerg Infect Dis 2004 10 : 961 962 discussion 2.
14. Haga IR, Bowie AG. Evasion of innate immunity by vaccinia virus. Parasitology 2005 130 (Suppl S11 25.
15. Moss B, Shisler JL. Immunology 101 at poxvirus U: immune evasion genes. Semin Immunol 2001 13 : 59 66.
16. Seet BT, Johnston JB, Brunetti CR et al. Poxviruses and immune evasion. Annu Rev Immunol 2003 21 : 377 423.
17. Sanchez-Puig JM, Sanchez L, Roy G, Blasco R. Susceptibility of different leukocyte cell types to Vaccinia virus infection. Virol J 2004 1 : 10.
18. Norbury CC, Malide D, Gibbs JS, Bennink JR, Yewdell JW. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol 2002 3 : 265 271.
19. Li P, Wang N, Zhou D, Yee CS, Chang CH, Brutkiewicz RR, Blum JS. Disruption of MHC class II-restricted antigen presentation by vaccinia virus. J Immunol 2005 175 : 6481 6488.
20. Yao Y, Li P, Singh P et al. Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II. Cell Immunol 2007 246 : 92 102.
21. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 1997 94 : 12053 12058.
22. Cook AD, Braine EL, Hamilton JA. The phenotype of inflammatory macrophages is stimulus dependent: implications for the nature of the inflammatory response. J Immunol 2003 171 : 4816 4823.
23. Martina BE, van Doornum G, Dorrestein GM, Niesters HG, Stittelaar KJ, Wolters MA, van Bolhuis HG, Osterhaus AD. Cowpox virus transmission from rats to monkeys, the Netherlands. Emerg Infect Dis 2006 12 : 1005 1007.
24. Mannie MD, Norris MS. MHC class-II-restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4- responders. Cell Immunol 2001 212 : 51 62.
25. Patel DM, Dudek RW, Mannie MD. Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes. Cell Immunol 2001 214 : 21 34.
26. Karupiah G, Buller RM, Van Rooijen N, Duarte CJ, Chen J. Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. J Virol 1996 70 : 8301 8309.
27. Panchanathan V, Chaudhri G, Karupiah G. Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. J Virol 2006 80 : 6333 6338.
28. Kastenmuller W, Drexler I, Ludwig H, Erfle V, Peschel C, Bernhard H, Sutter G. Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity. Virol 2006 350 : 276 288.
29. Roper RL. Characterization of the vaccinia virus A35R protein and its role in virulence. J Virol 2006 80 : 306 313.
30. Cory AH, Owen TC, Barltrop JA, Cory JG. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 1991 3 : 207 212.
31. Campos-Neto A, Ovendale P, Bement T, Koppi TA, Fanslow WC, Rossi MA, Alderson MR. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J Immunol 1998 160 : 2037 2041.
32. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, Jenkins MK. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 2003 19 : 47 57.
33. Rudensky A, Rath S, Preston-Hurlburt P, Murphy DB, Janeway CA Jr. On the complexity of self. Nature 1991 353 : 660 662.
34. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997 15 : 323 350.
35. Raschke WC, Baird S, Ralph P, Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 1978 15 : 261 267.
36. Humlova Z, Vokurka M, Esteban M, Melkova Z. Vaccinia virus induces apoptosis of infected macrophages. J Gen Virol 2002 83 (Pt 11 2821 2832.
37. Broder CC, Kennedy PE, Michaels F, Berger EA. Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors. Gene 1994 142 : 167 174.
38. Inaba K, Turley S, Iyoda T et al. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med 2000 191 : 927 936.
39. Stimpfling JH, Richardson A. Recombination within the histocompatibility-2 locus of the mouse. Genetics 1965 51 : 831 846.
40. Chahroudi A, Chavan R, Koyzr N, Waller EK, Silvestri G, Feinberg MB. Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. J Virol 2005 79 : 10397 10407.
41. Engelmayer J, Larsson M, Subklewe M, Chahroudi A, Cox WI, Steinman RM, Bhardwaj N. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J Immunol 1999 163 : 6762 6768.
42. Jenne L, Hauser C, Arrighi JF, Saurat JH, Hugin AW. Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function. Gene Ther 2000 7 : 1575 1583.
43. Matz-Rensing K, Ellerbrok H, Ehlers B, Pauli G, Floto A, Alex M, Czerny CP, Kaup FJ. Fatal poxvirus outbreak in a colony of New World monkeys. Vet Pathol 2006 43 : 212 218.
44. Gardella S, Andrei C, Poggi A, Zocchi MR, Rubartelli A. Control of interleukin-18 secretion by dendritic cells: role of calcium influxes. FEBS Lett 2000 481 : 245 248.
45. Reading PC, Smith GL. Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol 2003 77 : 9960 9968.